Global Primary Cells Market

Report Code: BIO236A

Publish Date: Nov 2022

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global primary cells market should reach $1.9 billion by 2027 from $1.3 billion in 2022 at a compound annual growth rate (CAGR) of 9.0% for the forecast period of 2022 to 2027.

Report Includes

  • 30 tables
  • A comprehensive overview of the global market for primary cells
  • Analyses of the global and regional market trends, with historic market revenue from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market potential for primary cells, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for primary cells market in USD million terms, and corresponding market share analysis based on product type, product origin, application, end user, and region
  • Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on manufacturers, suppliers, and major types of end users
  • Identification of the companies that are best positioned to meet the demand for primary cells because of their proprietary technologies, strategic alliances, or other advantages
  • Analysis of the vendor landscape based on their recent developments, financials, and segmental revenues
  • Descriptive company profiles of the leading global players, including Charles River Laboratories, Lonza, Merck KGaA and Thermo Fisher Scientific

Report Scope

This report aims to provide a comprehensive study of the global market for primary cells, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding primary cells. Segmentation is based on biological source type, tissue source type, application, end user, and region.

Industry growth drivers, restraints, trends, and opportunities in the primary cells market are also discussed in detail. The report also provides information on the competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $1.1 billion
Market size forecast $1.9 billion
Growth rate CAGR of 9.0% from 2022 to 2027
Units considered $ Millions
Segments covered Biological Source Type, Tissue Source Type, End User, Application
Regions covered North America, Europe, Asia Pacific, and Rest of the World (RoW)
Countries covered United States, Canada, Germany, France, U.K., Italy, Rest of Europe (Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia), China, Japan, India, Rest of Asia-Pacific (Australia, South Korea, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia), Latin America, Middle East and Africa
Key Market Drivers
  • Increasing Incidence of Chronic Diseases
  • Demand for Effective Drug Discovery and Development Process
  • Minimizing Animal Testing
  • Advances in Primary Cells Culture Technologies
  • Growing Spending on Pharmaceutical R&D
  • Strong Biotech Funding
  • Growing Applications in 3D Cell Culture Models
  • Growing Focus on Personalized Medicine
  • Growing Demand in Cell Therapy Research
Companies studied
AMERICAN TYPE CULTURE COLLECTION (ATCC)BIOIVT
CELL APPLICATIONS INC.CELL BIOLOGICS
CHARLES RIVER LABORATORIES INTERNATIONAL INC.DISCOVERY LIFE SCIENCES
LIFENET HEALTHLONZA
MERCK KGAAPELOBIOTECH GMBH
PROMOCELL GMBHSCIENCELL RESEARCH LABORATORIES
THERMO FISHER SCIENTIFIC INC.ZENBIO INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

• Since primary cells are more predictable indicators of human in vivo response than cell lines, it is becoming more acceptable tools in life sciences research, development of new drugs/therapies, and biological compounds (such as vaccines and therapeutic proteins) as well as in diverse applications where cell lines do not replicate the target biological system. • Demand for primary cells is increasing globally, with a drive toward effective and efficient cell culture for basic research and biopharmaceutical research. Harmonized cell culture media and reagents and cell maintenance protocols are essential to support optimal, consistent primary cell growth and maintain the tissue-specific characteristics to ensure the experiment’s reliability and validity. Improvements in cell isolation and cryopreservation, optimized media, and reagents, and streamlined use protocols have contributed to the explosion of primary cell use in research programs globally.
• With growing investment in biomedical research, researchers around the globe are putting forward higher requirements for the quantity and quality of well annotated, properly preserved biological samples and biodata for pharmaceutical and diagnostic research. Cell biology laboratories constantly seek innovative new technologies to enhance their experimental workflows and help deliver on their promise to drive the next research breakthrough. Primary cells are more predictable indicators of human in vivo responses and therefore integrating primary cells into cell-based research programs can deliver biologically relevant and meaningful data because. Using primary cells has become more commonplace and, in some cases, has been mandated to receive data approval or further research funding. • Cells are the foundation of any 3D model, and cell selection is a critical first step in the generation of any 3D model. Primary cells are increasingly used to build physiologically relevant 3D models to accelerate target identification and validation, investigation of mechanisms of action, and safety testing in drug discovery. • Primary cell providers are using advanced processing and isolation techniques for procuring and handling donor tissues, improved enzymatic dissociation cocktails and techniques, and standardized cryopreservation procedures to provide an extensive array of high-quality primary cells and culture media to improve experimental reliability and validity. This has contributed to the explosion of primary cell use in research programs globally. • Biologic therapies including cell and gene therapies are a new frontier in medicine. Primary cells are enabling advancements in gene editing, immunology, and cellular therapy leading to groundbreaking medical discoveries for life-threatening diseases.
The quantitative and qualitative assessment of the global primary cells market will help suppliers develop business/growth strategies, assess the market landscape, analyse their position in the current marketplace, and make informed business decisions regarding primary cells.
• Primary cell suppliers. • Researchers. • Primary cell start-ups. • Academic and commercial research organizations. • Consulting firms.
1. Thermo Fisher Scientific Inc. 2. Lonza. 3. Charles River Laboratories. 4. Merck KGaA. 5. Cell Biologics, Inc.
What key shifts/opportunities have been identified through the research? o With a drive toward effective and efficient cell culture for basic research, drug discovery, and biopharmaceutical development, the global primary cell market is expected to grow at rapid rate through the forecast period. o Enhancements in primary cell culture procurement, handling, and processing techniques, media formulation and cell maintenance protocols have also contributed to the explosion of primary cell use in research programs globally. o Given the ethical concerns and cost associated with living animal testing, worldwide efforts are underway to reduce the number of animals and animal models for discovery and preclinical studies. o The demand for HLA-typed primary cells is surging as researchers look to build ever-more predictive preclinical models for their personalized therapies.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Primary Cells Market108Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Market and Technology Background6Free
Chapter- 4: Market Dynamics12Free
Chapter- 5: Market Breakdown by Biological Source Type5Free
Chapter- 6: Market Breakdown by Tissue Source Type21Free
Chapter- 7: Market Breakdown by End User4Free
Chapter- 8: Market Breakdown by Application13Free
Chapter- 9: Market Breakdown by Region20Free
Chapter- 10: Competitive Landscape1Free
Chapter- 11: Company Profiles17Free

Related Reports

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Induced Pluripotent Stem Cells: Global Markets

Published - Feb 2024 | Publisher - Shehanaz Pathan | Code - BIO135E

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 and forecast to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 through 2028.

Cell-Based Assays: Technologies and Global Markets

Published - Aug 2022 | Publisher - BCC Publishing | Code - BIO080E

The global cell-based assays market should reach $47.3 billion by 2027 from $29.2 billion in 2022 at a compound annual growth rate (CAGR) of 10.2% for the forecast period of 2022 to 2027.

Cell Therapy Biomanufacturing: Global Markets

Published - Mar 2021 | Publisher - BCC Publishing | Code - BIO211A

The global market for cell therapy biomanufacturing should grow from $6.5 billion in 2020 to $10.2 billion by 2025, at compound annual growth rate (CAGR) of 9.4% for the period of 2020-2025.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Primary Cells Market
Sample Report